clinical trial · NCT00650052
Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg
HealthyZonisamide Capsules 100 mgZonegran® Capsules 100 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's zonisamide, 100 mg capsules to Elan's Zonegran® 100 mg capsules following a single, oral 100 mg (1 x 100 mg) dose administered under fasting conditions.
started
Nov 1, 2003
primary completion
Dec 1, 2003
completion
Dec 1, 2003
last updated
Apr 23, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Zonisamide Capsules (100 mg; Mylan) to Zonegran® Capsules (100 mg; Elan) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol